BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao Y, Yang Y, Pan D, Ding Y, Zhang H, Ye Y, Li J, Zhao L. HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia. Cancers (Basel) 2021;13:E243. [PMID: 33440739 DOI: 10.3390/cancers13020243] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Chen S, Zhu G, Xing X, Wan J, Cai J, Du J, Song L, Dai Z, Zhou J. LncRNA USP2-AS1 Promotes Hepatocellular Carcinoma Growth by Enhancing YBX1-Mediated HIF1α Protein Translation Under Hypoxia. Front Oncol 2022;12:882372. [DOI: 10.3389/fonc.2022.882372] [Reference Citation Analysis]
2 Zhang H, Zhou L, Zhou Y, Wang L, Jiang W, Liu L, Yue S, Zheng P, Liu H. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway. Life Sci 2021;285:119963. [PMID: 34536498 DOI: 10.1016/j.lfs.2021.119963] [Reference Citation Analysis]
3 Wang G, Ding B, Sun L, Guo J, Wang S, Li W, Zhang Y, Lv J, Qiu W. Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma. Front Genet 2022;13:859544. [DOI: 10.3389/fgene.2022.859544] [Reference Citation Analysis]
4 Li Z, Fang J, Chen S, Liu H, Zhou J, Huang J, Liu S, Peng Y. A Risk Model Developed Based on Necroptosis Predicts Overall Survival for Hepatocellular Carcinoma and Identification of Possible Therapeutic Drugs. Front Immunol 2022;13:870264. [PMID: 35422802 DOI: 10.3389/fimmu.2022.870264] [Reference Citation Analysis]
5 Gómez-Sintes R, Arias E. Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration. Mol Aspects Med 2021;:101025. [PMID: 34629183 DOI: 10.1016/j.mam.2021.101025] [Reference Citation Analysis]